The increased likelihood of an effective vaccine being developed is encouraging news for India. But even widespread vaccination would not restore India to economic health, and we would still expect output to remain substantially below its pre-virus trend for several years. Meanwhile, we’ve revised our rupee forecasts. The big picture is that the rupee will weaken further in trade-weighted terms over the coming years.
– We are sending this Weekly one day earlier than usual because our Singapore office is closed for a Public Holiday on Friday, 13th November –
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services